activistcompany
Soleus Capital Urges ESSA Pharma (EPIX) to Liquidate and Return Cash to Shareholders
Key Summary: On April 15, 2025, Soleus Capital (5.1%) urged ESSA Pharma to wind down operations and return cash
We focus exclusively on U.S. and Canadian stocks under $5 billion.
Our flagship: the Idea Generation Report. Each month, we spotlight 10–15 companies with compelling change narratives, found through rigorous, qualitative work.
We also summarize key developments such as shareholder activism, divestments, exploration of strategic alternatives, notable fund letters, and significant management changes.